Παραπομπή APA

Louis-Brennetot, C., Delattre, O., & Janoueix-Lerosey, I. (2020). High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma. EBioMedicine.

Παραπομπή Chicago Style

Louis-Brennetot, Caroline, Olivier Delattre, και Isabelle Janoueix-Lerosey. "High CD44 Expression Is Not a Prognosis Marker in Patients With High-risk Neuroblastoma." EBioMedicine 2020.

Παραπομπή MLA

Louis-Brennetot, Caroline, Olivier Delattre, και Isabelle Janoueix-Lerosey. "High CD44 Expression Is Not a Prognosis Marker in Patients With High-risk Neuroblastoma." EBioMedicine 2020.

Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.